For CLL/SLL patients, many of whom lived pretty everyday lives despite having incurable cancer, the COVID-19 pandemic changed everything by shining a light on the vulnerability of the immunocompromised.
Jill Gollinger, a CLL patient, wrote this article for her local community magazine about her push to get accepted into the Compassionate Use Program to prevent COVID-19 by receiving monthly infusions of Regen-Cov. She is hoping to avoid the same fearful news as Jill received. To learn more about Regeneron’s robust Compassionate Use Program, click here.
We learn from this intelligent and brave patient how COVID turned over her lives and her reactions to the threat.
Please, if you haven’t already, review, complete, and print our COVID ACTION PLAN. It could be lifesaving.
Stay strong. We are all in this together.
Brian Koffman MDCM (retired) MS Ed (he, him, his)
Co-Founder, Executive VP and Chief Medical Officer
CLL Society, Inc.